HYPERHEP B 220 [iU]/mL
HEPATITIS B IMMUNE GLOBULIN (HUMAN) · INJECTION · GRIFOLS USA, LLC
No Recall History
Plain English
HYPERHEP B is a injection containing hepatitis b immune globulin (human) at 220 [iU]/mL, taken intramuscular. Manufactured by GRIFOLS USA, LLC.
Key Facts
- Brand Name
- HYPERHEP B
- Generic Name
- HEPATITIS B IMMUNE GLOBULIN (HUMAN)
- NDC Code (Product)
13533-636- Manufacturer
- GRIFOLS USA, LLC
- Strength
- 220 [iU]/mL
- Dosage Form
- INJECTION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA101146
- Marketing Start
- 10/09/1996
Recall History
No Recall HistoryFrequently Asked Questions
What is HYPERHEP B used for?
HYPERHEP B contains HEPATITIS B IMMUNE GLOBULIN (HUMAN). It is a injection taken intramuscular. Consult your doctor for specific uses.
Is HYPERHEP B a controlled substance?
HYPERHEP B is not classified as a controlled substance by the DEA.
What is the generic name for HYPERHEP B?
The generic name for HYPERHEP B is HEPATITIS B IMMUNE GLOBULIN (HUMAN). There are 1 other brand versions of HEPATITIS B IMMUNE GLOBULIN (HUMAN).
What is the NDC code for HYPERHEP B 220 [iU]/mL?
The NDC (National Drug Code) for HYPERHEP B 220 [iU]/mL is 13533-636, listed by GRIFOLS USA, LLC.